Scholar Rock Holding Corp (SRRK)
29.94
+3.27
(+12.26%)
USD |
NASDAQ |
Nov 22, 16:00
29.94
0.00 (0.00%)
After-Hours: 16:00
Scholar Rock Total Liabilities (Quarterly): 99.94M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 99.94M |
June 30, 2024 | 93.24M |
March 31, 2024 | 84.51M |
December 31, 2023 | 85.82M |
September 30, 2023 | 83.02M |
June 30, 2023 | 82.40M |
March 31, 2023 | 86.07M |
December 31, 2022 | 97.93M |
September 30, 2022 | 97.04M |
June 30, 2022 | 94.62M |
March 31, 2022 | 94.66M |
December 31, 2021 | 132.37M |
September 30, 2021 | 111.13M |
June 30, 2021 | 115.40M |
Date | Value |
---|---|
March 31, 2021 | 120.05M |
December 31, 2020 | 127.54M |
September 30, 2020 | 100.44M |
June 30, 2020 | 74.19M |
March 31, 2020 | 77.06M |
December 31, 2019 | 83.48M |
September 30, 2019 | 66.75M |
June 30, 2019 | 67.96M |
March 31, 2019 | 73.46M |
December 31, 2018 | 74.71M |
September 30, 2018 | 6.675M |
June 30, 2018 | 7.366M |
March 31, 2018 | 6.801M |
December 31, 2017 | 115.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
74.19M
Minimum
Jun 2020
132.37M
Maximum
Dec 2021
97.04M
Average
94.64M
Median
Total Liabilities (Quarterly) Benchmarks
Cytokinetics Inc | 1.450B |
Regeneron Pharmaceuticals Inc | 8.116B |
Ocugen Inc | 21.31M |
Mirum Pharmaceuticals Inc | 435.87M |
NeuroBo Pharmaceuticals Inc | 9.193M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 179.13M |
Shareholders Equity (Quarterly) | 79.20M |